Senseonics Holdings (SENS) Research & Development (2015 - 2026)
Senseonics Holdings (SENS) reported Research & Development of $8.6 million for Q1 2026, up 17.98% year-over-year from $7.3 million in Q1 2025, and down 2.36% quarter-over-quarter from $8.8 million in Q4 2025.
Senseonics Holdings (SENS) Research & Development (2015 - 2026) Analysis & Trends
Senseonics Holdings (SENS) has 12 years of Research & Development data on file, last reported at $8.6 million in Q1 2026.
- Research & Development for Q1 2026 came in at $8.6 million, up 17.98% year-over-year; the trailing twelve-month figure through Mar 2026 was $32.9 million (down 13.42% YoY), and the FY2025 annual result was $31.6 million, down 23.22% from the prior year.
- Research & Development eased to $8.6 million in Q1 2026 per SENS's latest filing, from $8.8 million in the prior quarter.
- Over five years, Research & Development peaked at $12.8 million in Q2 2023 and troughed at -$37.7 million in Q4 2023.
- A 5-year average of $7.1 million and a median of $9.4 million in 2024 frame the typical range for Research & Development.
- The sharpest annual moves came in 2023 and 2024: Research & Development slumped 424.16% in 2023, then surged 124.83% in 2024.
- A 5-year view of Research & Development shows it stood at $11.6 million in 2022, then tumbled by 424.16% to -$37.7 million in 2023, then jumped by 124.83% to $9.4 million in 2024, then decreased by 5.78% to $8.8 million in 2025, then decreased by 2.36% to $8.6 million in 2026.
- Business Quant data shows SENS's Research & Development at $8.6 million in Q1 2026, $8.8 million in Q4 2025, and $7.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 722.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -461.27 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 145.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 28.80 Mn |
| 10 | Senseonics Holdings | 309.99 Mn | 245.67 Mn | 6.94 Mn | 8.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.61 Mn |
| Dec 31, 2025 | 8.82 Mn |
| Sep 30, 2025 | 7.76 Mn |
| Jun 30, 2025 | 7.72 Mn |
| Mar 31, 2025 | 7.30 Mn |
| Dec 31, 2024 | 9.36 Mn |
| Sep 30, 2024 | 10.55 Mn |
| Jun 30, 2024 | 10.80 Mn |
| Mar 31, 2024 | 10.44 Mn |
| Dec 31, 2023 | -37.70 Mn |
| Sep 30, 2023 | 12.77 Mn |
| Jun 30, 2023 | 12.83 Mn |
| Mar 31, 2023 | 12.41 Mn |
| Dec 31, 2022 | 11.63 Mn |
| Sep 30, 2022 | 10.99 Mn |
| Jun 30, 2022 | 9.30 Mn |
| Mar 31, 2022 | 7.80 Mn |
| Dec 31, 2021 | 7.66 Mn |
| Sep 30, 2021 | 7.20 Mn |
| Jun 30, 2021 | 7.11 Mn |